MENA region is recognized to be one of the top growing markets globally and pharmaceutical industry had reached about $ 36 Billions on 2016, such vast opportunities are very attractive to multinational and local manufacturers which in turn will result in extremely fierce competition.

In light of these opportunities and challenges, MMDS carefully decided to foster and articulate a business model that perfectly fits into the MENA markets and takes into consideration the proximities between markets and respect the distinctiveness of each market.

The business model endorsed underpin the fact that a sustainable pharmaceutical business could only be maintained by giving prime attention to scientific support along with marketing and promotional campaigns and not merely to be sales oriented corporate.

So MMDS as a master representative, who understands very well the MENA markets’ dynamics operates as a “hub” to facilitate the introduction of principles in to the MENA markets, MMDS takes the full responsibility in serving the principles products promotions, registration and delivering the premium services to partners and customers.

MMDS utilizes all its competences, know how , regulatory compliance, funds and solid distribution channel to professionally launch and brand its partners products.

MMDS manage, foresee and execute its short, mid and long term plans through a dedicated professional team and are responsible to scientifically promote and market the principles’ products to key customers.
The established distribution channels in each market are meticulously selected.

MMDS as a master enterprise is flexible to endorse numerous business model ranging from distribution, licensing, franchising or any other workable model that align with market needs.

DYNAMIC BUSINESS MODEL